Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 24.69
+0.78 (3.26%)
At close: Jul 10, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.05 billion as of July 10, 2026. Its market cap has decreased by -17.29% in one year.
Market Cap
9.05B
Enterprise Value
8.10B
Revenue
277.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.69
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.05B, a decrease of -27.43%. That is a compound annual growth rate of -9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 9.05B | -9.36% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 10.06B |
| Jiangxi Fushine Pharmaceutical | 9.87B |
| Nanjing Vazyme Biotech | 9.34B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.02B |
| Chengdu Easton Biopharmaceuticals | 8.98B |
| Pacific Shuanglin Bio-pharmacy | 8.76B |
| Sino Biological,Inc. | 8.52B |
| Acrobiosystems | 8.46B |